Why Hire CNP Holders Rigorous designation criteria ensure CNP-designated professionals will be superior contributors to an organization's bottom-line. Customers are assured of high-quality network systems being used to develop and support products and services.
The investigational CAM2038 buprenorphine subcutaneous injection products for treatment of opioid addiction are being developed as once-weekly and once-monthly formulations, each with multiple doses, to cover all phases of treatment from initiation through maintenance.
buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) sublingual tablets. (hereafter collectively termed âbuprenorphineâ) in office-based practices. Buprenorphine has been shown to be a safe and effective treatment of opioid dependence in. non-specialized, outpatient, office-based settings, including VA environments.